Suicidal ideations and suicide attempts after starting with aripiprazole, a new antipsychotic drug [4];Suïcidale ideaties en suïcidepogingen na instelling op aripiprazol, een nieuw antipsychoticum

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 7, 2006, Pages 401-

  Scholten, M R M ^a   Selten, J P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; NEUROLEPTIC AGENT; OLANZAPINE;

DRUG FATALITY; HUMAN; LETTER; PSYCHOSIS; SUICIDAL IDEATION; SUICIDE ATTEMPT;

EID: 33244491887     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, et al. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol. 2003;6:325-37.
2. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. N Engl J Med. 2005;353:1209-23.
3. El-Sayeh HG, Morganti C. Aripiprazole for schizophrenia [Cochrane review]. Cochrane Database SystRev. 2004;(2)CD004578.